Brent Pfeiffenberger

Brent Pfeiffenberger

Vorstandsvorsitzender bei CENTURY THERAPEUTICS, INC.

Vermögen: 6 Mio $ am 30.04.2024

Health Technology

Ursprung des Netzwerks ersten Grades von Brent Pfeiffenberger

EinheitArt der EinheitIndustrie
Public Company Biotechnology 14
10
Subsidiary Biotechnology 10

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Brent Pfeiffenberger

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Daphne Quimi

Corporate Officer/Principal

CELGENE Biotechnology

Adrienne Farid

Gregory Russotti

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Timothy Walbert

Douglas Carr

Corporate Officer/Principal

Corporate Officer/Principal

ROCHE HOLDING AG Pharmaceuticals: Major

Franz Humer

Hyam Levitsky

Chairman

Corporate Officer/Principal

Pharmaceuticals: Major

Franz Humer

Hyam Levitsky

Chief Operating Officer

Corporate Officer/Principal

AGENUS INC. Biotechnology

Hyam Levitsky

Director/Board Member

Miscellaneous Commercial Services

Hyam Levitsky

Adrienne Farid

Corporate Officer/Principal

Corporate Officer/Principal

AMICUS THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Diem

Daphne Quimi

Corporate Officer/Principal

Director of Finance/CFO

Pharmaceuticals: Major

Alessandro Riva

President

Pharmaceuticals: Major

Shane N. O. Williams

Corporate Officer/Principal

Pharmaceuticals: Major

Douglas Carr

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Mike Diem

Carlo Rizzuto

Director/Board Member

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Joseph Jimenez

Alessandro Riva

Chief Executive Officer

Corporate Officer/Principal

Stanford University College/University

Joseph Jimenez

Katherine Wood

Rachel Mears

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Daphne Quimi

Corporate Officer/Principal

University of Cambridge College/University

Martin Murphy

Shane N. O. Williams

Doctorate Degree

Doctorate Degree

Medical/Nursing Services

Hyam Levitsky

Corporate Officer/Principal

College/University

Mike Diem

Masters Business Admin

Rutgers State University of New Jersey College/University

Mike Diem

Douglas Carr

Gregory Russotti

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

The Johns Hopkins University College/University

Hyam Levitsky

Corporate Officer/Principal

Monmouth University College/University

Daphne Quimi

Undergraduate Degree

Investment Managers

Mike Diem

Private Equity Investor

Pharmaceuticals: Major

Joseph Jimenez

Alessandro Riva

Carlo Rizzuto

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Zocor Ltd.

Douglas Carr

Corporate Officer/Principal

Pharmaceuticals: Major

Timothy Walbert

Joseph Jimenez

Director/Board Member

Chairman

Miscellaneous Commercial Services

Hyam Levitsky

Corporate Officer/Principal

Miscellaneous Commercial Services

Hyam Levitsky

Corporate Officer/Principal

Miscellaneous Commercial Services

Daphne Quimi

Corporate Officer/Principal

Miscellaneous Commercial Services

Joseph Jimenez

Franz Humer

President

Corporate Officer/Principal

Biotechnology

Hyam Levitsky

Corporate Officer/Principal

Hospital/Nursing Management

Hyam Levitsky

Corporate Officer/Principal

Miscellaneous Commercial Services

Shane N. O. Williams

Corporate Officer/Principal

KITE PHARMA INC Biotechnology

David Tanen

Cynthia Butitta

Franz Humer

Founder

Director of Finance/CFO

Director/Board Member

The Johns Hopkins University School of Medicine College/University

Hyam Levitsky

Doctorate Degree

The Leonard N Stern School of Business College/University

Daphne Quimi

Masters Business Admin

JUNO THERAPEUTICS INC Biotechnology

Hyam Levitsky

Chief Tech/Sci/R&D Officer

School of Engineering & Applied Science College/University

Hyam Levitsky

Undergraduate Degree

REPLIMUNE GROUP, INC. Biotechnology

Hyam Levitsky

Director/Board Member

AMYLYX PHARMACEUTICALS, INC. Pharmaceuticals: Major

Daphne Quimi

Director/Board Member

Biotechnology

Cynthia Butitta

Martin Murphy

Director/Board Member

Chairman

Financial Conglomerates

Martin Murphy

Chief Executive Officer

Miscellaneous Commercial Services

Hyam Levitsky

Director/Board Member

Investment Managers

David Tanen

Rajul Jain

Consultant / Advisor

Private Equity Investor

ALLOGENE THERAPEUTICS, INC. Biotechnology

David Tanen

Franz Humer

Founder

Director/Board Member

AUTOLUS THERAPEUTICS PLC Biotechnology

Cynthia Butitta

Martin Murphy

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Martin Murphy

Chairman

CARISMA THERAPEUTICS, INC. Biotechnology

Hyam Levitsky

Adrienne Farid

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 39
Vereinigtes Königreich 8
Schweiz 4
Frankreich 2
Belgien 2

Sektoral

Health Technology 26
Commercial Services 11
Consumer Services 10
Finance 4
Health Services 3

Operativ

Director/Board Member 163
Corporate Officer/Principal 77
Independent Dir/Board Member 47
Chairman 35
Chief Executive Officer 26
  1. Börse
  2. Insiders
  3. Brent Pfeiffenberger
  4. Unternehmensverbindungen